StockNews.com lowered shares of Ultralife (NASDAQ:ULBI – Free Report) from a strong-buy rating to a buy rating in a research note published on Thursday.
Separately, Benchmark increased their target price on Ultralife from $13.00 to $14.00 and gave the stock a buy rating in a research report on Thursday, June 27th.
Check Out Our Latest Research Report on Ultralife
Ultralife Stock Up 0.9 %
Ultralife (NASDAQ:ULBI – Get Free Report) last issued its quarterly earnings results on Thursday, July 25th. The technology company reported $0.22 EPS for the quarter, topping analysts’ consensus estimates of $0.14 by $0.08. The business had revenue of $42.98 million during the quarter. Ultralife had a return on equity of 9.32% and a net margin of 5.96%.
Institutional Investors Weigh In On Ultralife
Several institutional investors have recently modified their holdings of the stock. Visionary Wealth Advisors raised its holdings in shares of Ultralife by 0.9% in the fourth quarter. Visionary Wealth Advisors now owns 1,082,246 shares of the technology company’s stock worth $7,381,000 after buying an additional 9,997 shares during the period. Janney Montgomery Scott LLC raised its holdings in shares of Ultralife by 10.0% in the first quarter. Janney Montgomery Scott LLC now owns 439,100 shares of the technology company’s stock worth $3,868,000 after buying an additional 40,000 shares during the period. Empowered Funds LLC raised its holdings in shares of Ultralife by 7.8% in the first quarter. Empowered Funds LLC now owns 31,396 shares of the technology company’s stock worth $277,000 after buying an additional 2,275 shares during the period. Vanguard Group Inc. raised its holdings in shares of Ultralife by 1.3% in the first quarter. Vanguard Group Inc. now owns 515,840 shares of the technology company’s stock worth $4,545,000 after buying an additional 6,640 shares during the period. Finally, Hillsdale Investment Management Inc. purchased a new stake in shares of Ultralife in the first quarter worth approximately $166,000. 30.68% of the stock is owned by institutional investors.
About Ultralife
Ultralife Corporation, together with its subsidiaries, designs, manufactures, installs, and maintains power, and communication and electronics systems worldwide. The company operates in two segments, Battery & Energy Products and Communications Systems. The Battery & Energy Products segment offers lithium 9-volt, cylindrical, thin lithium manganese dioxide, rechargeable, and other non-rechargeable batteries; lithium-ion cells, multi-kilowatt module lithium-ion battery systems, and uninterruptable power supplies; and rugged military and commercial battery charging systems and accessories, including smart chargers, multi-bay charging systems, and various cables.
See Also
- Five stocks we like better than Ultralife
- How to Invest in the Best Canadian Stocks
- 3 Small-Cap Stocks on the Way to Bigger and Better Days
- How to Most Effectively Use the MarketBeat Earnings Screener
- MarketBeat Week in Review – 9/30 – 10/4
- Manufacturing Stocks Investing
- Top Streaming Companies: Who’s Winning the Battle?
Receive News & Ratings for Ultralife Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ultralife and related companies with MarketBeat.com's FREE daily email newsletter.